用户48783635432019-04-09 14:29
【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验,此后股价上升13%
$Navidea生物制药(NAVB)$ Navidea根据FDA的反馈,宣布重启对NAV3-31的2b期临床试验计划,评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文
艾萨克的猫2018-10-23 23:00
$Navidea Biopharmaceuticals, Inc. (NAVB)$ Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the company will pr...查看全文
$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-02-01 AccNo: 0001437749-19-001640 Size: 33 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 9.01: Financial Statements and Exhibits 网页链接
$Navidea生物制药(NAVB)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-12-21 AccNo: 0001437749-18-022458 Size: 270 KB 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-11-30 AccNo: 0001437749-18-021404 Size: 52 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersI...
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-11-28 AccNo: 0001437749-18-021350 Size: 35 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersI...
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-09 AccNo: 0001437749-18-020274 Size: 7 MB 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-11-07 AccNo: 0001437749-18-019852 Size: 188 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-11-02 AccNo: 0001437749-18-019365 Size: 36 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersI...
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-10-30 AccNo: 0001437749-18-019062 Size: 38 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 9.01: Financial Statements and Exhibits ht...
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-10-09 AccNo: 0001437749-18-018057 Size: 19 KBItem 8.01: Other Events 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-10-05 AccNo: 0001437749-18-018026 Size: 98 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersI...